Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Iron deficiency anaemia in population of Polish patients--results of epidemiological screening study].
Krochmalczyk D, Piotrowska M, Skotnicki AB. Krochmalczyk D, et al. Among authors: piotrowska m. Pol Merkur Lekarski. 2005 Feb;18(104):184-8. Pol Merkur Lekarski. 2005. PMID: 17877127 Polish.
Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study).
Robak T, Jamroziak K, Gora-Tybor J, Stella-Holowiecka B, Konopka L, Ceglarek B, Warzocha K, Seferynska I, Piszcz J, Calbecka M, Kostyra A, Dwilewicz-Trojaczek J, Dmoszyñska A, Zawilska K, Hellmann A, Zdunczyk A, Potoczek S, Piotrowska M, Lewandowski K, Blonski JZ. Robak T, et al. Among authors: piotrowska m. J Clin Oncol. 2010 Apr 10;28(11):1863-9. doi: 10.1200/JCO.2009.25.9630. Epub 2010 Mar 8. J Clin Oncol. 2010. PMID: 20212251 Clinical Trial.
Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.
Robak T, Błoński J, Skotnicki AB, Piotrowska M, Wróbel T, Rybka J, Kłoczko J, Bołkun Ł, Budziszewska BK, Walczak U, Uss A, Fidecka M, Smolewski P. Robak T, et al. Among authors: piotrowska m. Eur J Haematol. 2018 May;100(5):465-474. doi: 10.1111/ejh.13042. Epub 2018 Mar 22. Eur J Haematol. 2018. PMID: 29427355 Clinical Trial.
Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG).
Iskierka-Jażdżewska E, Hus M, Giannopoulos K, Mądro E, Hołojda J, Piotrowska M, Zaucha JM, Piszczek W, Szeremet A, Wojciechowska M, Steckiewicz P, Knopińska-Posłuszny W, Osowiecki M, Drozd-Sokołowska J, Kumiega B, Kyrcz-Krzemień S, Hałka J, Dudziński M, Wieszczy P, Robak T, Warzocha K, Jamroziak K. Iskierka-Jażdżewska E, et al. Among authors: piotrowska m. Leuk Lymphoma. 2017 Oct;58(10):2485-2488. doi: 10.1080/10428194.2017.1292353. Epub 2017 Feb 28. Leuk Lymphoma. 2017. PMID: 28278701 No abstract available.
Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study.
Österborg A, Jewell RC, Padmanabhan-Iyer S, Kipps TJ, Mayer J, Stilgenbauer S, Williams CD, Hellmann A, Furman RR, Robak T, Hillmen P, Trnêný M, Dyer MJ, Piotrowska M, Kozak T, Gupta IV, Phillips JL, Goldstein N, Struemper H, Losic N, Lisby S, Wierda WG; Hx-CD20-406 Study Investigators. Österborg A, et al. Among authors: piotrowska m. Haematologica. 2015 Aug;100(8):e311-4. doi: 10.3324/haematol.2014.121459. Epub 2015 Mar 13. Haematologica. 2015. PMID: 25769539 Free PMC article. No abstract available.
Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemia.
Robak T, Blonski JZ, Gora-Tybor J, Calbecka M, Dwilewicz-Trojaczek J, Boguradzki P, Dmoszynska A, Kowal M, Kloczko J, Piszcz J, Stella-Holowiecka B, Sulek K, Kuliczkowski K, Potoczek S, Warzocha K, Lech-Maranda E, Skotnicki AB, Piotrowska M, Moskwa A, Zawilska K, Jamroziak K. Robak T, et al. Among authors: piotrowska m. Leuk Lymphoma. 2014 Mar;55(3):606-10. doi: 10.3109/10428194.2013.809073. Epub 2013 Nov 14. Leuk Lymphoma. 2014. PMID: 23721512 Clinical Trial.
Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia.
Wierda WG, Kipps TJ, Mayer J, Stilgenbauer S, Williams CD, Hellmann A, Robak T, Furman RR, Hillmen P, Trneny M, Dyer MJ, Padmanabhan S, Piotrowska M, Kozak T, Chan G, Davis R, Losic N, Wilms J, Russell CA, Osterborg A; Hx-CD20-406 Study Investigators. Wierda WG, et al. Among authors: piotrowska m. J Clin Oncol. 2010 Apr 1;28(10):1749-55. doi: 10.1200/JCO.2009.25.3187. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194866 Free PMC article. Clinical Trial.
Therapy with CD4+CD25+ T regulatory cells - should we be afraid of cancer?
Gliwiński M, Piotrowska M, Iwaszkiewicz-Grześ D, Urban-Wójciuk Z, Trzonkowski P. Gliwiński M, et al. Among authors: piotrowska m. Contemp Oncol (Pozn). 2019;23(1):1-6. doi: 10.5114/wo.2019.84110. Epub 2019 Apr 5. Contemp Oncol (Pozn). 2019. PMID: 31061630 Free PMC article. Review.
Multielemental Analysis of Tobacco Plant and Tobacco Products by TXRF.
Majewska U, Piotrowska M, Sychowska I, Banas D, Kubala-Kukus A, Wudarczyk-Mocko J, Stabrawa I, Gózdz S. Majewska U, et al. Among authors: piotrowska m. J Anal Toxicol. 2018 Jul 1;42(6):409-416. doi: 10.1093/jat/bky016. J Anal Toxicol. 2018. PMID: 29566234
Impact of inter-hospital transfers on the prevalence of resistant pathogens in a hospital-community system.
Piotrowska MJ, Sakowski K, Lonc A, Tahir H, Kretzschmar ME. Piotrowska MJ, et al. Epidemics. 2020 Oct 21;33:100408. doi: 10.1016/j.epidem.2020.100408. Online ahead of print. Epidemics. 2020. PMID: 33128935 Free article.
118 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback